North America Adenosine Triphosphate Swab Test Markets, 2021-2027: Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System to Gain Traction - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Adenosine Triphosphate Swab Test Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type and Application" report has been added to ResearchAndMarkets.com's offering.

The North America Adenosine Triphosphate (ATP) swab test market is expected to reach US$ 132.91 million by 2027 from US$ 69.83 million in 2019. The market is estimated to grow at a CAGR of 8.4% from 2020 to 2027.

The growth of the market is attributed to the key driving factors such as rising prevalence of healthcare associated infections (HAI) and increasing emphasis on food safety. However, the limitations of ATP swab tests hinder the market growth.

Healthcare-associated infectious (HAI) are caused while receiving treatments or therapies in healthcare facilities. These infections are related to surgical procedures and medical instruments used during operations. The rising prevalence of HAIs is one of the prominent factors driving the demand for ATP swab tests.

Also, the utilization of adenosine triphosphate is a major indicator of cleanliness and sterilization in food & beverages. Hence, the rising incidence of foodborne diseases and food contamination is prominently expected to drive the growth of the North America Adenosine Triphosphate (ATP) swab test market during the forecast period.

The COVID-19 outbreak pandemic is adversely affecting countries in North America. In the US, all sanitization processes at hospitals, medical establishments, and high touch point surfaces in public places utilize Adenosine Triphosphate (ATP) Swab Test to confirm the surface is free from microorganisms, which boosts the growth of the North America Adenosine Triphosphate (ATP) swab test market.

However, the growing number of COVID-19 confirmed cases has resulted in disruption in the supply chain due to a long period of lockdown, which hampers the market growth.

Key Market Dynamics

Market Drivers

• Rising Prevalence of Healthcare-Associated Infections (HAI)
• Increasing Emphasis on Food Safety

Market Restraint

• Limitations of ATP Swab Tests

Market Opportunity

• Growing Spending on Patient Safety and Care

Future Trend

• Development of Adenylate (A3) Concentration Based Modern Sterility Monitoring System

Company Profiles

• 3M
• Hygiena, LLC
• Charm Sciences
• Neogen Corporation
• Ecolab
• MERCK KGaA
• Ruhof Healthcare Corporation
• LuminUltra Technologies Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/wx1ssk